Companies
Nuritas
Nuritas PeptiStrong cleared the FDA GRAS process, removing restrictions on its use in foods, beverages and supplements across the United States.
- Country
- Ireland
FDA GRAS
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $42 million Series C funding round | foodnavigator.com · nuritas.com |
| Founded | 2014 | prospeo.io |
| Regulatory approval | FDA GRAS status for PeptiStrong in the United States | nuritas.com · nutritionaloutlook.com |
| Headquarters | Dublin, Ireland | prospeo.io |
| Revenue | estimated between $7.5 million and $150 million annually medium confidence | prospeo.io |
Independent sources: foodnavigator.com · nutritionaloutlook.com · prospeo.io
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioactive peptides for nutrition | food-alt-protein | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.